INVITAE CORP's ticker is NVTA and the CUSIP is 46185L103. A total of 370 filers reported holding INVITAE CORP in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $911,350 | -46.0% | 1,505,866 | +0.8% | 0.00% | – |
Q2 2023 | $1,688,937 | -13.4% | 1,494,634 | +3.5% | 0.00% | -100.0% |
Q1 2023 | $1,950,441 | +257.8% | 1,444,771 | +392.9% | 0.00% | – |
Q4 2022 | $545,175 | -25.1% | 293,105 | -1.0% | 0.00% | – |
Q3 2022 | $728,000 | -4.3% | 296,087 | -5.0% | 0.00% | – |
Q2 2022 | $761,000 | -63.7% | 311,711 | +18.5% | 0.00% | -100.0% |
Q1 2022 | $2,096,000 | +58.9% | 263,137 | +204.8% | 0.00% | – |
Q4 2021 | $1,319,000 | -46.1% | 86,330 | +0.3% | 0.00% | -100.0% |
Q3 2021 | $2,447,000 | -2.5% | 86,083 | +15.6% | 0.00% | 0.0% |
Q2 2021 | $2,511,000 | +64.9% | 74,437 | +86.8% | 0.00% | – |
Q1 2021 | $1,523,000 | +10.6% | 39,849 | +21.0% | 0.00% | – |
Q4 2020 | $1,377,000 | -93.1% | 32,942 | -92.9% | 0.00% | -100.0% |
Q3 2020 | $20,012,000 | +178.4% | 461,642 | +94.5% | 0.01% | +133.3% |
Q2 2020 | $7,189,000 | +3605.7% | 237,370 | +1566.7% | 0.00% | – |
Q1 2020 | $194,000 | -96.4% | 14,242 | -93.7% | 0.00% | -100.0% |
Q1 2019 | $5,320,000 | +3992.3% | 227,166 | +1187.5% | 0.00% | – |
Q2 2018 | $130,000 | +2500.0% | 17,644 | +4814.8% | 0.00% | – |
Q2 2015 | $5,000 | – | 359 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EMORY UNIVERSITY | 104,861 | $1,560,000 | 2.11% |
Baker Brothers Advisors | 6,554,967 | $97,538,000 | 0.86% |
SECTORAL ASSET MANAGEMENT INC | 929,765 | $13,835,000 | 0.58% |
Camber Capital Management LP | 500,000 | $7,440,000 | 0.51% |
Rock Springs Capital Management LP | 400,000 | $5,952,000 | 0.43% |
Redmile Group, LLC | 181,224 | $2,563,000 | 0.21% |
Perceptive Advisors | 299,583 | $2,306,000 | 0.14% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 166,666 | $2,480,000 | 0.08% |
CORRADO ADVISORS, LLC | 11,860 | $176,000 | 0.08% |
Orbimed Advisors | 456,666 | $6,795,000 | 0.05% |